Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Blake Turvey

Orthopaedic Trauma Austin, TX Medical Doctor

NPI 1528417698 CMS profile 2786551

4700 Seton Center Pkwy Ste 200, Austin, TX 78759

Open in the dashboard

General payments

$13,876

119 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Blake Turvey of Austin, TX is reported in the CMS Open Payments database as having received $13,876 across 119 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,041 26
2024 General $2,076 29
2023 General $6,090 54
2022 General $2,559 9
2021 General $111 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Blake Turvey
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Blake Turvey were reported at $3,041. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Blake Turvey Orthopaedic Trauma median Middle half National median
2019 $0 $1,475 $264–$6,401 $163
2020 $0 $596 $120–$4,020 $114
2021 $111 $919 $171–$4,697 $132
2022 $2,559 $1,547 $272–$7,240 $149
2023 $6,090 $1,330 $247–$5,875 $160
2024 $2,076 $1,288 $277–$6,797 $164
2025 $3,041 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $5,399 51 payments
  2. Acumed LLC $3,786 19 payments
  3. Core Surgical Group $1,328 7 payments
  4. Medinc of Texas $1,259 2 payments
  5. Arthrex, Inc. $615 9 payments
  6. Medical Device Business Services, Inc. $500 1 payment
  7. DePuy Synthes Sales Inc. $302 14 payments
  8. Zimmer Biomet Holdings, Inc. $280 6 payments
  9. Smith+Nephew, Inc. $186 5 payments
  10. Sanara MedTech Inc. $108 1 payment
  11. Other $112 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $5,124 21 payments
  2. Food and Beverage $4,389 91 payments
  3. Consulting Fee $2,213 4 payments
  4. Education $1,200 1 payment
  5. Grant $950 2 payments
Products named General payments · program years 2021–2025
  1. MAKO $2,920 24 payments
  2. ACUMED Elbow $2,870 10 payments
  3. ACUMED Elbow $1,238 2 payments
  4. ACUMED Elbow $1,238 2 payments
  5. PRO $550 8 payments
  6. OsteoMed Foot & Ankle $531 2 payments
  7. OsteoMed Foot & Ankle $531 2 payments
  8. INFINITY $328 2 payments
  9. OMEGA $322 2 payments
  10. ACTISHIELD $274 4 payments
  11. Other $4,134 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

337

Median for Orthopedic Surgery: 203

Drug cost

$3,072

Median for Orthopedic Surgery: $1,433

Branded share of claims

22.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 38 $1,064
Oxycodone Hcl Generic 75 $461
Ibuprofen Generic 30 $273
Gabapentin Generic 30 $260
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 20 $215
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 29 $201
Meloxicam Generic 47 $173
Methocarbamol Generic 17 $173
Acetaminophen-Codeine Acetaminophen With Codeine Brand 12 $98
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 14 $70

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 137 billing codes

Paid by Medicare

$184,482

Of which drugs: $704

Medicare patients

271

Average age 76

Services billed

1,501

190 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Depression 39%
Osteoporosis 35%
Ischemic heart disease 32%
Diabetes 30%
Atrial fibrillation 28%
Chronic kidney disease 28%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 21 86 $64
Injection, ketorolac tromethamine, per 15 mg J1885 Office 15 48 $24

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record